TrialTranslational neurodegeneration2020

Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study.

Heinz Reichmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.